Delivery Order W81K0225DA026-W81K0225FA153
- Not listed
- This is a delivery order awarded to Qiagen, LLC by the Defense Health Agency (DHA) for the provision of QuantiFERON-TB Gold Plus testing products and services. The order is placed under a larger indefinite delivery vehicle (IDV) contract with a ceiling value of $84,947. QuantiFERON-TB Gold Plus is a blood test used to detect tuberculosis infection. Qiagen is a manufacturer of diagnostic kits, equipment, and bioinformatics software that supports biomedical research, public health, and...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Qiagen, LLC, a division of the international provider Qiagen N.V., for QUANTIFERON TB GOLD PLUS REAGENT. The $150,394.42 contract has a completion date of September 30, 2023 and does not have a set-aside designation. Qiagen is a manufacturer of molecular diagnostic products and services that supports federal agencies' biomedical research, public health, and healthcare programs. The...
- This contract award is for a task order under a larger indefinite delivery vehicle (IDV) held by Qiagen, LLC, a division of the parent company Qiagen N.V. The task order is for the procurement of QuantiFERON-TB Plus reagents, which are used for tuberculosis testing. The contract has a firm fixed price of $83,674.00 and a period of performance running through September 30, 2024. The awarding agency is the Defense Health Agency, a component of the Department of Defense. Qiagen has provided similar...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 8, awarded a $228,396.40 firm-fixed-price purchase order contract to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is for the supply of QuantiFERON-TB Gold Plus test kits and controls, which are used for tuberculosis screening and detection. The contract does not have a set-aside designation. Qiagen, headquartered in Germantown, Maryland, has...
- This is a $178,685.64 firm-fixed-price BPA call contract awarded by the Veterans Integrated Service Network 15 (VISN 15), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract is for the supply of QuantiFERON (QFT) TB Gold Plus testing kits over a period ending on July 14, 2028. The contract does not have a set-aside designation, indicating Qiagen was able to compete effectively in...
- This is a federal delivery order awarded by the Bureau of Medicine and Surgery (a component of the Department of Defense) to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the provision of QuantiFERON-TB Gold reference laboratory packs and QuantiFERON-TB Gold tubes, which are used for tuberculosis testing. The contract has a ceiling value of $126,476.34 and a final performance date of June 1, 2016. This award is related to a larger federal...
- This is a Firm Fixed Price Delivery Order awarded by the Veterans Integrated Service Network 17, a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract, valued at $106,687.50, is for the supply of QuantiFERON-TB Gold Plus reagents. It is an Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a period of performance through November 30, 2026. The contract does not have a set-aside designation. Qiagen,...
- Qiagen, LLC has been awarded a Blanket Purchase Agreement call valued at $1,192.45 for QuantiFERON TB Gold Plus supplies. The contract, issued by Veterans Integrated Service Network 15, a component of the Department of Veterans Affairs, was awarded on July 15, 2024, with an ultimate completion date of July 14, 2025. This firm fixed-price BPA call requires no set-aside designation, allowing the foreign-owned manufacturer to compete directly in the open federal marketplace. The place of...
- This is a delivery order awarded to Qiagen, LLC, a subsidiary of Qiagen N.V., by the Veterans Integrated Service Network 9 (VISN 9) of the U.S. Department of Veterans Affairs. The contract is for the provision of QuantiFERON TB Gold Plus reagents, which are used for tuberculosis testing. The contract has a firm fixed price of $124,285.77 and a period of performance through September 30, 2024. This award is associated with a larger indefinite delivery/indefinite quantity (IDIQ) contract that...
- Qiagen, LLC was awarded a $80,343.09 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 to provide Quantiferon TB reagents and supplies. As the prime contractor, Qiagen will deliver the requested products to support tuberculosis screening and diagnosis efforts at locations within the Germantown, Maryland area. No set-aside provisions were specified for this award placed against an unspecified...
- W81K0225DA026Indefinite Delivery Contract
- W81K0225DA026-W81K0225FA153Delivery Order
The Defense Health Agency awarded a $97,179 delivery order to Qiagen, LLC for QuantiFERON TB Gold-Plus assays (reagents and controls) to support the detection of Mycobacterium tuberculosis. The contract is firm fixed price with no set-aside designation and extends through September 30, 2026. Work will be performed at Qiagen's facility in Germantown, Maryland. This delivery order represents a child contract under a larger indefinite delivery vehicle, leveraging Qiagen's existing blanket purchase agreement with the Defense Health Agency valued at $6.5 million for pharmaceutical products and diagnostic supplies. Qiagen is a foreign-owned molecular diagnostics manufacturer with extensive experience providing tuberculosis testing reagents and advanced diagnostic solutions to federal agencies. The QuantiFERON TB Gold-Plus assay is a widely-used interferon-gamma release assay for tuberculosis detection and is a standard diagnostic tool across military medical facilities. The Defense Health Agency procurement supports the department's medical readiness and occupational health programs by ensuring adequate supply of validated diagnostic reagents for active duty personnel and military healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/17/25 |